Roffman Miller Associates Inc. PA boosted its position in Colgate-Palmolive (NYSE:CL) by 1.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 203,718 shares of the company’s stock after purchasing an additional 2,932 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in Colgate-Palmolive were worth $15,370,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. Jacobi Capital Management LLC grew its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares in the last quarter. Krilogy Financial LLC grew its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares in the last quarter. Calton & Associates Inc. purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $126,000. Captrust Financial Advisors purchased a new stake in Colgate-Palmolive in the 2nd quarter valued at $122,000. Finally, AlphaMark Advisors LLC grew its holdings in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares in the last quarter. 72.85% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive (NYSE:CL) opened at $71.46 on Friday. Colgate-Palmolive has a twelve month low of $68.19 and a twelve month high of $77.91. The company has a market capitalization of $62,340.77, a PE ratio of 24.82, a P/E/G ratio of 2.64 and a beta of 0.75. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42.
Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period last year, the business posted $0.75 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.6% on a year-over-year basis. equities analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 70.18%.
Several analysts have issued reports on CL shares. Citigroup dropped their target price on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Monday, October 23rd. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price for the company in a report on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $77.71.
In related news, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.44, for a total transaction of $972,160.00. Following the completion of the transaction, the senior vice president now directly owns 100,508 shares in the company, valued at approximately $6,979,275.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total value of $68,389.64. Following the transaction, the insider now owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The disclosure for this sale can be found here. Insiders have sold a total of 421,019 shares of company stock valued at $30,031,097 over the last 90 days. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.